Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Preliminary data from phase Ib trial of gedatolisib plus palbociclib and endocrine therapy

April 9, 2021

Novartis presents new KMT2A inhibitors

April 9, 2021

Indian researchers patent ENPP1 inhibitors

April 9, 2021

FDA places partial clinical hold on first-in-human study of RVU-120

April 9, 2021

Patient dosing starts in first-in-human study of DS-1594 as treatment of AML and ALL

April 9, 2021

Premetastatic niche is prepared via leaky gut in colorectal cancer

April 9, 2021

Stearoyl-CoA-desaturase inhibitor YTX-7739 shows efficacy in glioblastoma mouse models

April 8, 2021

Patient recruitment ongoing in phase III study of Tookad VTP in upper tract urothelial carcinoma

April 8, 2021

RMC-5552 enters phase I development for relapsed/refractory solid tumors

April 8, 2021

Calico and AbbVie initiate first-in-human study of ABBV-CLS-484

April 8, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 15, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
GABA signaling linked to immune resistance in some tumors
BioWorld
Certain cancers that contain organized clusters of immune cells known as tertiary lymphoid structures (TLS) do not respond to treatment as well as expected. Even...